Design Therapeutics (DSGN) Expected to Announce Quarterly Earnings on Wednesday

Design Therapeutics (NASDAQ:DSGN) is projected to announce its Q1 2025 earnings results before the market opens on Wednesday, May 14th. Analysts expect Design Therapeutics to post earnings of ($0.28) per share for the quarter.

Design Therapeutics (NASDAQ:DSGN) last announced its quarterly earnings results on Monday, March 10th. The company reported ($0.24) EPS for the quarter, beating the consensus estimate of ($0.28) by $0.04. On average, analysts expect Design Therapeutics to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Design Therapeutics Trading Down 16.7 %

Shares of NASDAQ:DSGN opened at $3.63 on Wednesday. The company has a market capitalization of $206.16 million, a price-to-earnings ratio of -4.27 and a beta of 1.77. Design Therapeutics has a 12-month low of $2.60 and a 12-month high of $7.77. The business has a 50-day moving average price of $4.12 and a 200 day moving average price of $5.00.

About Design Therapeutics

Design Therapeutics, Inc a biopharmaceutical company, researches, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates for inherited diseases caused by nucleotide repeat expansion.